Merrell S W, Ames S A, Nelson E W, Renlund D G, Karwande S V, Burton N A, Sullivan J J, Jones K W, Gay W A
Department of Surgery, University of Utah College of Medicine, Salt Lake City 84132.
Arch Surg. 1989 Aug;124(8):889-94. doi: 10.1001/archsurg.1989.01410080019002.
Serious complications involving the alimentary tract are commonly reported following cardiac transplantation, and may be associated with significant morbidity and mortality. The aim of this report was to review the incidence, severity, and outcome of abdominal complications in our heart transplant population in whom we used corticosteroid-sparing protocols for immunosuppression. From March 1985 through September 1988, 178 patients underwent 185 cardiac transplants. Twenty-six cardiac transplant recipients (15%) sustained 33 major abdominal complications, including gastrointestinal bleeding (n = 8), pancreatitis (n = 8), bowel perforation (n = 6), cholecystitis (n = 4), and miscellaneous other problems (n = 7). Operative therapy was required in 61% of cases. No deaths were caused by the gastrointestinal complications of their operative management. Corticosteroid-sparing immunosuppression may be responsible for the low incidence of abdominal morbidity, and early, aggressive surgical intervention may reduce subsequent mortality.
心脏移植后常报告涉及消化道的严重并发症,且可能与显著的发病率和死亡率相关。本报告的目的是回顾我们采用免疫抑制激素节省方案的心脏移植受者人群中腹部并发症的发生率、严重程度及结局。1985年3月至1988年9月,178例患者接受了185次心脏移植。26例心脏移植受者(15%)出现了33例主要腹部并发症,包括胃肠道出血(8例)、胰腺炎(8例)、肠穿孔(6例)、胆囊炎(4例)及其他各种问题(7例)。61%的病例需要手术治疗。手术治疗的胃肠道并发症未导致死亡。免疫抑制激素节省方案可能是腹部发病率低的原因,早期积极的手术干预可能降低后续死亡率。